Published in Am J Surg Pathol on September 01, 2011
β-catenin activation drives thymoma initiation and progression in mice. Oncotarget (2015) 0.90
Proteomic Signatures of Thymomas. PLoS One (2016) 0.75
Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer. J Clin Oncol (2005) 5.10
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol (2009) 3.12
Origin and evolution of the adaptive immune system: genetic events and selective pressures. Nat Rev Genet (2009) 3.11
The amphioxus genome illuminates vertebrate origins and cephalochordate biology. Genome Res (2008) 3.04
Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet (2008) 2.89
Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol (2002) 2.45
Frequent EGFR mutations in brain metastases of lung adenocarcinoma. Int J Cancer (2006) 2.11
Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol (2006) 2.11
Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation. Blood (2010) 2.04
Variable lymphocyte receptors in hagfish. Proc Natl Acad Sci U S A (2005) 1.99
Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg (2002) 1.91
Structural diversity of the hagfish variable lymphocyte receptors. J Biol Chem (2006) 1.89
Genomic analysis of immunity in a Urochordate and the emergence of the vertebrate immune system: "waiting for Godot". Immunogenetics (2003) 1.75
Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma. Cancer (2002) 1.66
VLR-based adaptive immunity. Annu Rev Immunol (2012) 1.56
Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg (2003) 1.55
The role of lymph-node dissection in the treatment of upper urinary tract cancer: a multi-institutional study. BJU Int (2008) 1.53
Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol (2011) 1.52
Invasive group A streptococcal infection in pregnancy. J Infect (2010) 1.48
Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung. Cancer Sci (2007) 1.47
A novel type of E3 ligase for the Ufm1 conjugation system. J Biol Chem (2009) 1.47
Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest (2005) 1.46
Crystal structure of a chaperone complex that contributes to the assembly of yeast 20S proteasomes. Nat Struct Mol Biol (2008) 1.45
CNS lymphomatoid granulomatosis with lymph node and bone marrow involvements. Neuropathology (2008) 1.40
Cooperation of multiple chaperones required for the assembly of mammalian 20S proteasomes. Mol Cell (2006) 1.37
ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Oncol (2014) 1.37
Identification of a third variable lymphocyte receptor in the lamprey. Proc Natl Acad Sci U S A (2010) 1.37
Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol (2004) 1.36
Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis. Am J Clin Pathol (2006) 1.36
Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib. Clin Cancer Res (2007) 1.34
Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D. J Immunol (2008) 1.31
Primary bone lymphoma: a new and detailed characterization of 28 patients in a single-institution study. Jpn J Clin Oncol (2007) 1.31
A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg (2003) 1.29
Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis. Anticancer Res (2011) 1.24
Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. Am J Pathol (2002) 1.19
Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am J Surg Pathol (2003) 1.19
Malignant glomus tumor of the lung. Pathol Int (2003) 1.18
A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer. Gastroenterology (2010) 1.17
Abundant neutrophil extracellular traps in thrombus of patient with microscopic polyangiitis. Front Immunol (2012) 1.17
Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. Am J Pathol (2002) 1.15
Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features. Clin Cancer Res (2005) 1.15
Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma. Cancer (2006) 1.15
Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum Pathol (2002) 1.13
Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol (2006) 1.12
Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma. Cancer Sci (2009) 1.12
Clinicopathological analysis of early-stage gastric cancers detected after successful eradication of Helicobacter pylori. Helicobacter (2011) 1.12
Minute pulmonary meningothelial-like nodules: clinicopathologic analysis of 121 patients. Hum Pathol (2009) 1.11
Multiple lung adenocarcinomas showing ground-glass opacities on thoracic computed tomography. Ann Thorac Surg (2006) 1.10
Primary mediastinal large B-cell lymphoma: a single-institution clinical study in Japan. Int J Hematol (2004) 1.10
Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer. Clin Cancer Res (2005) 1.08
Decreased proteasomal activity causes age-related phenotypes and promotes the development of metabolic abnormalities. Am J Pathol (2011) 1.08
Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. Arch Pathol Lab Med (2008) 1.07
Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk. Cancer (2002) 1.07
Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma. Pancreas (2011) 1.06
Autoimmune pancreatitis associated with hemorrhagic pseudocysts: a case report and literature review. Intern Med (2008) 1.06
Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Lung Cancer (2005) 1.06
Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. Chest (2005) 1.06
Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy. Lung Cancer (2005) 1.06
Natural killer cell receptors in the horse: evidence for the existence of multiple transcribed LY49 genes. Eur J Immunol (2004) 1.05
Transcriptome analysis of hagfish leukocytes: a framework for understanding the immune system of jawless fishes. Dev Comp Immunol (2004) 1.04
Endobronchial ultrasonography with a guide sheath in the diagnosis of benign peripheral diseases. Ann Thorac Surg (2012) 1.03
Hagfish leukocytes express a paired receptor family with a variable domain resembling those of antigen receptors. J Immunol (2005) 1.03
Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X. Immunogenetics (2003) 1.03
Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients. Oncol Rep (2010) 1.03
Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma. Cancer Sci (2007) 1.00
Frequent EGFR mutations in noninvasive bronchioloalveolar carcinoma. Int J Cancer (2006) 0.99
Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma. Clin Cancer Res (2007) 0.99
Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma. Oncol Rep (2010) 0.99
Development and validation of diagnostic prediction model for solitary pulmonary nodules. Respirology (2007) 0.98
Beta-catenin mutations in pulmonary blastomas: association with morule formation. J Pathol (2003) 0.98
Identification of the rat IgA Fc receptor encoded in the leukocyte receptor complex. Immunogenetics (2003) 0.98
Corticomedullary differentiation and maturational arrest in thymomas. Histopathology (2013) 0.97
Right- and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis. J Surg Res (2005) 0.97
Enteropathy-type T-cell lymphoma showing repeated small bowel rupture and refractoriness to chemotherapy: a case report. Jpn J Clin Oncol (2002) 0.96
Differential modulation of gene expression among rat tissues with warm ischemia. Exp Mol Pathol (2004) 0.96
CD133 expression: a potential prognostic marker for non-small cell lung cancers. Int J Clin Oncol (2013) 0.96
Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract. J Urol (2010) 0.96
p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors. Cancer Sci (2013) 0.95
Whole genome comparison of allelic imbalance between noninvasive and invasive small-sized lung adenocarcinomas. Cancer Res (2009) 0.95
Evaluation of the sclerotherapeutic efficacy of ethanol, polidocanol, and OK-432 using an in vitro model. Dermatol Surg (2007) 0.95
Rat CD4+CD8+ macrophages kill tumor cells through an NKG2D- and granzyme/perforin-dependent mechanism. J Immunol (2008) 0.95
Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer. Breast Cancer (2013) 0.94
Solitary capillary hemangioma of the lung: report of 2 resected cases detected by high-resolution CT. Am J Surg Pathol (2006) 0.94
Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma. Ann Surg Oncol (2011) 0.94
HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells. J Clin Invest (2014) 0.94